| Balance Sheets | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | 672 | 599 | 547 | 675 |
| Accounts receivable (net of allowance for doubtful accounts of 12 in 2025 and 14 in 2024) | 1,484 | 1,484 | 1,457 | 1,358 |
| Inventories (excludes inventories of 247 in 2025 and 215 in 2024 classified in other assets) | 1,488 | 1,454 | 1,362 | 1,321 |
| Other current assets | 1,056 | 1,081 | 1,005 | 994 |
| Total current assets | 4,700 | 4,618 | 4,371 | 4,348 |
| Property, plant and equipment, net | 1,290 | 1,266 | 1,197 | 1,168 |
| Goodwill | 4,680 | 4,680 | 4,680 | 4,680 |
| Intangibles, net | 1,340 | 1,362 | 1,417 | 1,414 |
| Other assets | 1,542 | 1,574 | 1,491 | 1,491 |
| Total assets | 13,552 | 13,500 | 13,156 | 13,101 |
| Current portion of long-term debt | - | - | 20 | 20 |
| Current portion of long-term debt and short-term borrowings | 45 | 115 | - | - |
| Trade accounts payable | 1,074 | 1,067 | 1,006 | 1,153 |
| Accrued and other current liabilities | 1,444 | 1,420 | 1,413 | 1,411 |
| Income taxes payable | 116 | 194 | 176 | 134 |
| Total current liabilities | 2,679 | 2,796 | 2,615 | 2,718 |
| Long-term debt | 8,783 | 8,781 | 8,936 | 8,860 |
| Deferred income taxes | 62 | 69 | 69 | 74 |
| Other noncurrent liabilities | 1,122 | 1,121 | 994 | 977 |
| Total liabilities | 12,646 | 12,767 | 12,614 | 12,629 |
| Common stock, 0.01 par value authorized - 500,000 issued and outstanding - 259,983 in 2025 and 257,799 in 2024 | 3 | 3 | 3 | 3 |
| Additional paid-in capital | 159 | 139 | 130 | 108 |
| Retained earnings | 1,318 | 1,163 | 1,026 | 1,010 |
| Accumulated other comprehensive loss | -574 | -572 | -617 | -649 |
| Total stockholders equity | 906 | 733 | 542 | 472 |
| Total liabilities and stockholders equity | 13,552 | 13,500 | 13,156 | 13,101 |
Organon & Co. (OGN)
Organon & Co. (OGN)